SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-021322
Filing Date
2021-09-01
Accepted
2021-09-01 17:08:01
Documents
13
Period of Report
2021-08-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20210901_8k.htm   iXBRL 8-K 39401
  Complete submission text file 0001437749-21-021322.txt   187404

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20210827.xsd EX-101.SCH 4028
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20210827_def.xml EX-101.DEF 13400
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20210827_lab.xml EX-101.LAB 17561
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20210827_pre.xml EX-101.PRE 13371
6 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20210901_8k_htm.xml XML 4284
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 211230946
SIC: 2860 Industrial Organic Chemicals